Olimel 5.7% E 2.84 g (l-Threonine EMULSION) 2.84 G

OlimeL 5.7% E 2.84 G is an intravenous emulsion containing L-Threonine, designed to support nutritional needs. This product by Baxter Corporation provides essential amino acids for intravenous administration.

Strength

2.84 G

Pack Size

1000/1500/2000/2500ML

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

OlimeL 5.7% E 2.84 G is used to provide nutritional support for patients who cannot consume food orally. It contains L-Threonine, an essential amino acid that plays a crucial role in protein synthesis and overall health. This emulsion is often used in clinical settings to ensure patients receive adequate nutrition.

Side Effects

When administered intravenously, OlimeL 5.7% E 2.84 G provides essential amino acids directly into the bloodstream. This can help maintain proper nutritional levels and support various bodily functions. Some users may experience mild effects, but these are generally well-tolerated.

Precautions & Warnings

OlimeL 5.7% E 2.84 G should be administered under medical supervision. It is important to follow proper handling and storage guidelines to ensure the emulsion remains effective. Always check for any signs of contamination before use.

Avoid Interactions

OlimeL 5.7% E 2.84 G may interact with other medications or supplements. It is important to inform healthcare providers about all current treatments before administration. Certain substances may affect the absorption or effectiveness of this emulsion.

Frequently Asked Questions

OlimeL 5.7% E 2.84 G is used to provide nutritional support for patients who cannot consume food orally, containing essential amino acids like L-Threonine.

OlimeL 5.7% E 2.84 G is administered intravenously, providing essential amino acids directly into the bloodstream.

Common effects include the provision of essential amino acids to support various bodily functions, with mild effects generally well-tolerated.

OlimeL 5.7% E 2.84 G should be administered under medical supervision and handled according to proper guidelines to ensure effectiveness and safety.

OlimeL 5.7% E 2.84 G may interact with other medications or supplements, so it is important to inform healthcare providers about all current treatments.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.